Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes: 2010–2013 to 2016–2019

Mary E. Lacy; Katherine E. Lee; Omer Atac; Kory Heier; John Fowlkes; Anna Kucharska-Newton; Daniela C. Moga

doi:10.2337/cd23-0051

Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes: 2010–2013 to 2016–2019

Mary E. Lacy, Katherine E. Lee, Omer Atac, Kory Heier, John Fowlkes, Anna Kucharska-Newton, Daniela C. Moga

Research output: Contribution to journal › Article › peer-review

2 Citations (SciVal)

Abstract

Prior studies suggest that only ~30% of patients with type 1 diabetes use continuous glucose monitoring (CGM), but most studies to date focused on children and young adults seen by endocrinologists or in academic centers. This study examined national trends in CGM utilization among commercially insured children and adults with type 1 diabetes. Overall, CGM utilization was 20.12% in 2010–2013 and 49.78% in 2016–2019, reflecting a 2.5-fold increase in utilization within a period of <10 years. Identifying populations with low CGM use is a necessary first step in developing targeted interventions to increase CGM uptake.

Original language	English
Pages (from-to)	388-397
Number of pages	10
Journal	Clinical Diabetes
Volume	42
Issue number	3
DOIs	https://doi.org/10.2337/cd23-0051
State	Published - Jun 2024

Bibliographical note

Publisher Copyright:
© 2024 by the American Diabetes Association.

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/cd23-0051

Cite this

@article{d5629d520e7d46d3a48e121351e33c5e,

title = "Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes: 2010–2013 to 2016–2019",

abstract = "Prior studies suggest that only ~30% of patients with type 1 diabetes use continuous glucose monitoring (CGM), but most studies to date focused on children and young adults seen by endocrinologists or in academic centers. This study examined national trends in CGM utilization among commercially insured children and adults with type 1 diabetes. Overall, CGM utilization was 20.12% in 2010–2013 and 49.78% in 2016–2019, reflecting a 2.5-fold increase in utilization within a period of <10 years. Identifying populations with low CGM use is a necessary first step in developing targeted interventions to increase CGM uptake.",

author = "Lacy, {Mary E.} and Lee, {Katherine E.} and Omer Atac and Kory Heier and John Fowlkes and Anna Kucharska-Newton and Moga, {Daniela C.}",

note = "Publisher Copyright: {\textcopyright} 2024 by the American Diabetes Association.",

year = "2024",

month = jun,

doi = "10.2337/cd23-0051",

language = "English",

volume = "42",

pages = "388--397",

journal = "Clinical Diabetes",

issn = "0891-8929",

publisher = "American Diabetes Association Inc.",

number = "3",

}

TY - JOUR

T1 - Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes

T2 - 2010–2013 to 2016–2019

AU - Lacy, Mary E.

AU - Lee, Katherine E.

AU - Atac, Omer

AU - Heier, Kory

AU - Fowlkes, John

AU - Kucharska-Newton, Anna

AU - Moga, Daniela C.

PY - 2024/6

Y1 - 2024/6

N2 - Prior studies suggest that only ~30% of patients with type 1 diabetes use continuous glucose monitoring (CGM), but most studies to date focused on children and young adults seen by endocrinologists or in academic centers. This study examined national trends in CGM utilization among commercially insured children and adults with type 1 diabetes. Overall, CGM utilization was 20.12% in 2010–2013 and 49.78% in 2016–2019, reflecting a 2.5-fold increase in utilization within a period of <10 years. Identifying populations with low CGM use is a necessary first step in developing targeted interventions to increase CGM uptake.

AB - Prior studies suggest that only ~30% of patients with type 1 diabetes use continuous glucose monitoring (CGM), but most studies to date focused on children and young adults seen by endocrinologists or in academic centers. This study examined national trends in CGM utilization among commercially insured children and adults with type 1 diabetes. Overall, CGM utilization was 20.12% in 2010–2013 and 49.78% in 2016–2019, reflecting a 2.5-fold increase in utilization within a period of <10 years. Identifying populations with low CGM use is a necessary first step in developing targeted interventions to increase CGM uptake.

UR - http://www.scopus.com/inward/record.url?scp=85202013145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85202013145&partnerID=8YFLogxK

U2 - 10.2337/cd23-0051

DO - 10.2337/cd23-0051

M3 - Article

AN - SCOPUS:85202013145

SN - 0891-8929

VL - 42

SP - 388

EP - 397

JO - Clinical Diabetes

JF - Clinical Diabetes

IS - 3

ER -

Patterns and Trends in Continuous Glucose Monitoring Utilization Among Commercially Insured Individuals With Type 1 Diabetes: 2010–2013 to 2016–2019

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this